Drug intelligence / Profile preview

citiolone

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous
01

Overview

Citiolone is a small molecule drug used primarily in liver therapy as a hepatoprotectant and antioxidant. It is a derivative of the amino acid cysteine and acts as a hydroxyl free radical scavenger, providing protection against oxidative stress. Its mechanism involves increasing glutathione levels and accelerating superoxide dismutase (SOD), thereby reducing cellular damage from reactive oxygen species. Citiolone has also been studied for its neuroprotective effects in models of neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease, where it inhibits oxidative stress-induced cytotoxicity. Additionally, it has been used as a mucolytic agent and for the treatment of chronic hepatitis[1][5][7][8].

Brand names
CitiolaseMucorexSitilon
Other names
citioloneCitiolonaCitiolonumDL-N-Acetylhomocysteine thiolactoneThioxidreneAcetamide, N-(tetrahydro-2-oxo-3-thienyl)-3-Acetamidotetrahydro-2-thiophenoneN-(2-Oxotetrahydrothiophenyl)acetamideN-Acetylhomocysteine thiolactoneN-Acetyl-dl-homocysteine thiolactone2-Acetamido–4–mercaptobutyric acid gamma-thiolactoneN-(2-Oxothiolan–3–yl)acetamideN-Acetylhmocysteinethiolactone

Beyond the preview

Go deeper on citiolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on citiolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call